Endocrinology

We have carefully reviewed this court ruling, which addresses the consent of children and young people to the use of puberty suppressing drugs as part of the treatment of gender dysphoria. We consider that the ruling should not have implications for the general ethical or legal framework for childre...

Dr Andrea Srur, Programme Manager for the national Diabetes Quality Programme, describes the recent successes from this project and the challenges presented by the COVID-19 outbreak.

We look ahead to plans for digital growth charts, which will be available to parents and carers in 2021.

The National Paediatric Diabetes Audit (NDPA) 2018/19 Annual Report on Care Processes and Outcomes was published today by the Royal College of Paediatrics and Child Health (RCPCH).

On 20 January 2023, the National Paediatric Diabetes Audit (NPDA) held their first hybrid National Conference, with over 90 in-person attendees and over 300 people joining virtually. Staff from all professional groups working in diabetes and other stakeholders came together to learn about how NPDA d...

NHSE is conducting a review of the specification for this service and associated policies for 2020. It will also set up an independent expert group to make recommendations regarding the use of puberty suppressants and cross-sex hormones.

BPSU surveillance of outcome of symptomatic glucocorticoid induced adrenal suppression commenced in September 2020. This study will estimate how many people are presenting to healthcare providers with adrenal suppression causing symptoms because of them currently or previously taking glucocorticoid ...